Pfizer U.S. drug sales decline on falling Covid vaccine revenue

Pfizer reported a year-over-year decline in U.S. drug sales, driven by reduced revenue from Covid-19 vaccines. This reflects the ongoing normalization of pandemic-era demand, a trend already established in prior quarters. The impact on broader markets is limited, as the decline is company-specific and expected.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works